• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 HOMA-IR 评估腹腔镜胃袖状切除术或胃旁路手术后胰岛素抵抗的改善情况。

Evaluation of insulin resistance improvement after laparoscopic sleeve gastrectomy or gastric bypass surgery with HOMA-IR.

机构信息

Diabetes Surgery Centre, General Surgery Department, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University).

出版信息

Biosci Trends. 2017;11(6):675-681. doi: 10.5582/bst.2017.01307.

DOI:10.5582/bst.2017.01307
PMID:29311450
Abstract

Our purpose was to explore the remission of insulin resistance after bariatric surgery to discover the mechanism of diabetes remission excluding dietary factors. A retrospective case control study was conducted on patients with type 2 diabetes, who underwent laparoscopic sleeve gastrectomy (LSG) or laparoscopic gastric bypass surgery (LGB) in Beijing Shijitan Hospital from April 1, 2012 to April 1, 2013. The laboratory and anthropometric data was analyzed pre-surgery and during a 2-year follow-up. HOMA-IR was calculated and evaluated. The two surgical procedures were compared. No significant difference in complete remission rate was observed between the two groups (LGB group: 62.1%, LSG group: 60.0%, p = 0.892). HOMA-IR was reduced to a stable level at the 3 month after surgery. The cut-off value of HOMA-IR was 2.38 (sensitivity: 0.938, specificity: 0.75) and 2.33 (sensitivity: 0.941, specificity: 0.778) respectively for complete remission after LSG or LGB surgery. Insulin resistance was improved while GLP-1 and Ghrelin was changed significantly in patients with type 2 diabetes prior to weight loss either in the LSG or LGB group. HOMA-IR decreased to less than the cut-off value at the 3 month and was closely related to complete remission. The mechanism of bariatric surgery was not due just to simply dietary factors or body weight loss but also the remission of insulin resistance.

摘要

我们的目的是探索减重手术后胰岛素抵抗的缓解情况,以发现除饮食因素外糖尿病缓解的机制。对 2012 年 4 月 1 日至 2013 年 4 月 1 日在北京世纪坛医院接受腹腔镜袖状胃切除术(LSG)或腹腔镜胃旁路手术(LGB)的 2 型糖尿病患者进行了回顾性病例对照研究。分析了术前和 2 年随访期间的实验室和人体测量学数据。计算并评估了 HOMA-IR。比较了两种手术程序。两组之间完全缓解率无显著差异(LGB 组:62.1%,LSG 组:60.0%,p=0.892)。HOMA-IR 在术后 3 个月降至稳定水平。HOMA-IR 的截断值分别为 2.38(灵敏度:0.938,特异性:0.75)和 2.33(灵敏度:0.941,特异性:0.778),用于 LSG 或 LGB 手术后完全缓解。无论在 LSG 还是 LGB 组,体重减轻前的 2 型糖尿病患者的胰岛素抵抗均得到改善,同时 GLP-1 和 Ghrelin 明显改变。HOMA-IR 在 3 个月时降至低于截断值,与完全缓解密切相关。减重手术的机制不仅是由于单纯的饮食因素或体重减轻,还与胰岛素抵抗的缓解有关。

相似文献

1
Evaluation of insulin resistance improvement after laparoscopic sleeve gastrectomy or gastric bypass surgery with HOMA-IR.采用 HOMA-IR 评估腹腔镜胃袖状切除术或胃旁路手术后胰岛素抵抗的改善情况。
Biosci Trends. 2017;11(6):675-681. doi: 10.5582/bst.2017.01307.
2
Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance.袖状胃切除术和 Roux-en-Y 胃旁路术在纠正胰岛素抵抗方面同样有效。
Int J Surg. 2013;11(4):309-13. doi: 10.1016/j.ijsu.2013.02.007. Epub 2013 Feb 24.
3
Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study.日本袖状胃切除术联合十二指肠-空肠旁路术治疗肥胖重症糖尿病患者的疗效:一项回顾性多中心研究
Obes Surg. 2018 Feb;28(2):497-505. doi: 10.1007/s11695-017-2874-4.
4
Laparoscopic sleeve gastrectomy versus laparoscopic gastric bypass: A retrospective cohort study.腹腔镜袖状胃切除术与腹腔镜胃旁路术:一项回顾性队列研究。
Int J Surg. 2019 Jul;67:47-53. doi: 10.1016/j.ijsu.2019.05.004. Epub 2019 May 20.
5
Evolution of low-grade systemic inflammation, insulin resistance, anthropometrics, resting energy expenditure and metabolic syndrome after bariatric surgery: a comparative study between gastric bypass and sleeve gastrectomy.减重手术后低度全身炎症、胰岛素抵抗、人体测量学、静息能量消耗和代谢综合征的演变:胃旁路术与袖状胃切除术的比较研究。
J Visc Surg. 2013 Sep;150(4):269-75. doi: 10.1016/j.jviscsurg.2013.08.005. Epub 2013 Sep 7.
6
[Impacts of laparoscopic bariatric surgery on GLP-1 and Ghrelin level in patients with type 2 diabetes mellitus].[腹腔镜减肥手术对2型糖尿病患者胰高血糖素样肽-1和胃饥饿素水平的影响]
Zhonghua Wai Ke Za Zhi. 2013 Apr;51(4):323-7.
7
Efficacy of laparoscopic gastric bypass laparoscopic sleeve gastrectomy in treating obesity combined with type-2 diabetes.腹腔镜胃旁路术与腹腔镜袖状胃切除术治疗肥胖合并 2 型糖尿病的疗效比较。
Br J Biomed Sci. 2021 Jan;78(1):35-40. doi: 10.1080/09674845.2020.1798578. Epub 2020 Aug 24.
8
Laparoscopic Ileal Interposition with Diverted Sleeve Gastrectomy Versus Laparoscopic Transit Bipartition with Sleeve Gastrectomy for Better Glycemic Outcomes in T2DM Patients.腹腔镜回肠插入术联合袖状胃切除术转流与腹腔镜袖状胃切除术转流二分法对2型糖尿病患者改善血糖结局的比较
Obes Surg. 2018 Jan;28(1):77-86. doi: 10.1007/s11695-017-2803-6.
9
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial.胃旁路术与袖状胃切除术治疗 2 型糖尿病患者(Oseberg):一项单中心、三盲、随机对照试验。
Lancet Diabetes Endocrinol. 2019 Dec;7(12):912-924. doi: 10.1016/S2213-8587(19)30344-4. Epub 2019 Oct 31.
10
The Impact of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Intestinal Microbiota Differs from that of Laparoscopic Sleeve Gastrectomy in Japanese Patients with Obesity.腹腔镜袖状胃切除术联合空肠回肠旁路术对肥胖日本患者肠道微生物群的影响不同于腹腔镜袖状胃切除术。
Clin Drug Investig. 2018 Jun;38(6):545-552. doi: 10.1007/s40261-018-0638-0.

引用本文的文献

1
Gastric bypass surgery in morbid obesity: Influence on thyroid function tests and insulin resistance status.病态肥胖患者的胃旁路手术:对甲状腺功能检查及胰岛素抵抗状态的影响
Caspian J Intern Med. 2024 Spring;15(2):294-298. doi: 10.22088/cjim.15.2.294.
2
Change in Adipokines and Gastrointestinal Hormones After Bariatric Surgery: a Meta-analysis.减重手术后脂联素和胃肠激素的变化:荟萃分析。
Obes Surg. 2023 Mar;33(3):789-806. doi: 10.1007/s11695-022-06444-8. Epub 2023 Jan 6.
3
Retrospective Comparison of SADI-S Versus RYGB in Chinese with Diabetes and BMI< 35kg/m: a Propensity Score Adjustment Analysis.
回顾性比较 SADI-S 与 RYGB 在 BMI<35kg/m2 的中国糖尿病患者中的疗效:倾向评分调整分析。
Obes Surg. 2021 Dec;31(12):5166-5175. doi: 10.1007/s11695-021-05708-z. Epub 2021 Sep 30.
4
Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study.肥胖日本患者减重手术后2型糖尿病缓解的决定因素:一项回顾性队列研究
Diabetol Int. 2021 Jan 28;12(4):379-388. doi: 10.1007/s13340-021-00493-7. eCollection 2021 Oct.
5
Preintervention Clinical Determinants and Measured β-Cell Function As Predictors of Type 2 Diabetes Remission After Roux-en-Y Gastric Bypass Surgery.干预前临床决定因素及测量的β细胞功能作为Roux-en-Y胃旁路手术后2型糖尿病缓解的预测指标
Diabetes Care. 2021 Aug 15;44(10):2427-34. doi: 10.2337/dc21-0395.
6
Evaluation of Lipoprotein Profile and Residual Risk Three Years After Bariatric Surgery.评价减重手术后 3 年的脂蛋白谱和残余风险。
Obes Surg. 2021 Sep;31(9):4033-4044. doi: 10.1007/s11695-021-05543-2. Epub 2021 Jul 10.
7
Remission of Type 2 Diabetes and Sleeve Gastrectomy in Morbid Obesity: a Comparative Systematic Review and Meta-analysis.2 型糖尿病缓解与病态肥胖胃袖状切除术:一项比较系统评价和荟萃分析。
Obes Surg. 2019 Dec;29(12):4066-4076. doi: 10.1007/s11695-019-04199-3.